What began as a small crack in the solid concept of early detection and early treatment for prostate cancer has now widened and spread.

A ‘paradigm shift’ in the treatment of prostate cancer has been heralded following the findings of a recent trial of new focal therapy. It appears for the first time in print in the Journal of Urology on Monday 4 April 2011.

"The cancer itself never did any damage. It was the treatments that razed me — the surgery, radiation and hormones producing a catalog of miseries that included impotence, incontinence and hot flashes."


Should we continue any test that offers some chance of preventing a death, regardless of the odds or the costs associated with the testing?

Our current medical care system is not designed to do well at making these decisions. 


Experts soften recommendations on cancer screenings

Universal routine screenings may not always be the best option for improving public health

Our Mission

The Peter Michael Foundation is on a quest to discover and underwrite the most promising tools and technologies for the identification, treatment and management of prostate cancer. The Foundation is finding and funding truly innovative research with exceptional scientists at world-class institutions. The Foundation is currently underwriting postdoctoral research fellows at: Memorial Sloan-Kettering Cancer Center University of California, Institute for Quantitative Biosciences Stanford University School of Medicine, Molecular Imaging Scholars Discussions are also underway with M.D. Anderson Cancer Center, University of Nebraska Medical Center, and Duke University School of Medicine.



See the 2012 Year in Review and 2012 Prostate Cancer Research Reports by clicking on these links

Best-of-Class Research Investment Strategy

The Foundation employs a Best-of-Class Research Investment Strategy, operating similar to a venture capital model, where we source, vet, fund and track high potential prostate cancer research opportunities from around the US. Collaboation is the critical fifth step in the process. In partnership with Sir Peter Michael's UK foundation, The Pelican Cancer Foundation, The Peter Michael Foundation sponsors a Prostate Cancer Colloquium every other May in which scientists, researchers and clinicians from Europe and the United States come together to share research findings, discuss and debate the implications, and inspire progress and solutions. It is the intention of The Peter Michael Foundation to serve as a catalyst in achieving true medical breakthroughs that are significant, innovative, effective and newsworthy.



facebook